Home > > Materials And Chemicals > > 2,4-Dichlorobenzyl Alcohol Market Size, Share, And Industry Trends 2031
Id: CBI_1572 | Pages: 318 | Format : PDF | Published : | Author : Amit Sati | Category : Materials And Chemicals
2,4-dichlorobenzyl alcohol market size is estimated to reach over USD 45.12 Million by 2031 from a value of USD 30.90 Million in 2023 and is projected to grow by USD 31.85 Million in 2024, growing at a CAGR of 4.8% from 2024 to 2031.
2,4-dichlorobenzyl alcohol is a chemical compound commonly used as an antiseptic and preservative in pharmaceutical and personal care products. Known for its antimicrobial properties, it is frequently included in throat lozenges, mouthwashes, and nasal sprays to help prevent and treat infections. This compound is valued for its effectiveness in inhibiting bacterial growth, making it a popular choice in formulations designed to maintain hygiene and control microbial contamination. Pharmaceutical companies and manufacturers of hygiene products are key end-users, incorporating this compound in products aimed at enhancing consumer health and safety. The increasing awareness of hygiene and infection control in both medical and consumer settings supports steady market growth.
The 2,4-dichlorobenzyl alcohol is widely used as an antimicrobial agent, particularly in throat lozenges and sprays, to treat symptoms of sore throat and throat infections due to its bacteriostatic properties. The pharmaceutical industry relies on 2,4-dichlorobenzyl alcohol for its effectiveness in oral care products, while the personal care sector uses it in various formulations as a preservative to inhibit microbial growth. As consumer awareness regarding throat infections and personal hygiene grows, particularly in response to increased focus on health and wellness, the demand for antimicrobial agents like 2,4-dichlorobenzyl alcohol continues to rise, supporting the 2,4-dichlorobenzyl alcohol market expansion.
One of the primary restraints in the 2,4-dichlorobenzyl alcohol market growth is the stringent regulatory framework surrounding its use, particularly in pharmaceutical and personal care products. Regulatory agencies in regions like North America and Europe closely monitor and control the allowable concentrations of antimicrobial agents in consumer products due to potential health concerns. Excessive or prolonged exposure to 2,4-dichlorobenzyl alcohol can cause irritation or allergic reactions, limiting its use in certain applications. Additionally, the extensive testing and compliance requirements for safety and efficacy increase production costs, posing challenges for manufacturers, particularly when entering highly regulated markets.
The growing exploration of 2,4-dichlorobenzyl alcohol in veterinary medicine and agriculture presents a promising opportunity for market expansion. In veterinary care, it is being studied as an antimicrobial additive in topical applications for livestock to prevent infections and enhance animal health. In agriculture, its use as a preservative in plant treatment solutions is gaining interest, as it helps in controlling microbial growth on plants and during storage. The adoption of alcohol in these sectors not only broadens its market applications but also offers manufacturers 2,4-dichlorobenzyl alcohol market opportunities to diversify their product offerings in less saturated markets.
Based on purity, the market is segmented into 98% purity, 99% purity, and other purities.
The 99% purity segment accounted for the largest revenue share of the total 2,4-dichlorobenzyl alcohol market share in 2023.
The 98% purity segment is anticipated to register the fastest CAGR during the forecast period.
Based on application, the market is segmented into preservatives, insecticides, chemical intermediates, and others.
The preservative segment accounted for the largest revenue share of the overall 2,4-dichlorobenzyl alcohol market share in 2023.
The insecticide segment is anticipated to register the fastest CAGR during the forecast period.
Based on the end-user industry, the market is segmented into pharmaceutics, cosmetics, agriculture, food & beverage, and others.
The pharmaceutics segment accounted for the largest revenue share of 40.24% in 2023.
The agriculture segment is anticipated to register the fastest CAGR during the forecast period.
The regions covered are North America, Europe, Asia Pacific, the Middle East and Africa, and Latin America.
Asia Pacific region was valued at USD 8.41 Million in 2023. Moreover, it is projected to grow by USD 8.71 Million in 2024 and reach over USD 13.04 Million by 2031. Out of this, China accounted for 32.4% of the total market share. Growing awareness of hygiene and healthcare products and the increasing prevalence of throat infections in these countries are key drivers. China's and India's expanding pharmaceutical manufacturing capabilities also support the adoption of 2,4-Dichlorobenzyl Alcohol as an ingredient in medicinal products. However, regulatory challenges and variations in quality standards across countries may restrict market expansion.
North America holds a significant share of the 2,4-dichlorobenzyl alcohol market, primarily due to its extensive use in pharmaceuticals, specifically in throat lozenges and antiseptic products. The U.S. leads in the market, supported by a strong pharmaceutical industry and high awareness of healthcare and hygiene products. Increased incidence of respiratory infections drives the need for products containing alcohol. However, stringent FDA regulations on pharmaceutical ingredients may pose challenges to product approvals in the region.
Europe is a key market, with high demand from Germany, the UK, and France, where it is widely used in over-the-counter (OTC) cold and cough medications. The region's high incidence of seasonal flu and throat infections, combined with stringent quality standards for pharmaceuticals, drives the market. The European Union's focus on consumer safety and strict regulations on chemicals used in medicinal products also ensure the quality of products. However, compliance with EU regulations can increase production costs, affecting the 2,4-dichlorobenzyl alcohol market demand.
The regional trends analysis shows that the Middle East & Africa region shows steady development in the market, with demand primarily from Saudi Arabia, the UAE, and South Africa. The region's focus on improving healthcare infrastructure and rising awareness of personal hygiene products support market growth. Increases in respiratory illnesses and the need for OTC pharmaceuticals also contribute to the market. However, limited local production capabilities and reliance on imports for pharmaceutical ingredients may limit market progress.
As per the 2,4-dichlorobenzyl alcohol market analysis, Latin America is an emerging market, led by Brazil and Mexico. The region's market is fueled by a growing pharmaceutical sector and rising healthcare awareness, particularly in cold and throat-care products. Brazil's increasing focus on OTC medications and Mexico's expanding healthcare sector support market growth. However, economic fluctuations and limited access to advanced production facilities present challenges for consistent market advancement.
The 2,4-dichlorobenzyl alcohol market is highly competitive with major players providing treatments to the national and international markets. Key players are adopting several strategies in research and development (R&D), product innovation, and end-user launches to hold a strong position in the global 2,4-dichlorobenzyl alcohol market. Key players in the 2,4-dichlorobenzyl alcohol industry include -
Report Attributes | Report Details |
Study Timeline | 2018-2031 |
Market Size in 2031 | USD 45.12 Million |
CAGR (2024-2031) | 4.8% |
By Purity |
|
By Application |
|
By End-User Industry |
|
By Region |
|
Key Players |
|
North America | U.S. Canada Mexico |
Europe | U.K. Germany France Spain Italy Russia Benelux Rest of Europe |
APAC | China South Korea Japan India Australia ASEAN Rest of Asia-Pacific |
Middle East and Africa | GCC Turkey South Africa Rest of MEA |
LATAM | Brazil Argentina Chile Rest of LATAM |
Report Coverage |
|
In 2023, the 2,4-dichlorobenzyl alcohol market was USD 30.90 million.
In 2031, the market size of 2,4-dichlorobenzyl alcohol is expected to reach USD 45.12 million.
Their purity, application, and end-user industry are the segments covered in this report.
BASF SE (Germany), Lanxess AG (Germany), Nouryon (Netherlands), Merck KGaA (Germany), Thermo Fisher Scientific Inc. (USA), Toronto Research Chemicals Inc. (Canada), Alfa Aesar (USA), Tokyo Chemical Industry Co., Ltd. (Japan), Henan CoreyChem Co., Ltd. (China), Santa Cruz Biotechnology, Inc. (USA) are the major players in the 2,4-dichlorobenzyl alcohol market.